ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...
The harmful effects of pollution on the skin need to be combated with a holistic skincare approach, which should include ...
Objective To produce a best evidence synthesis of the clinical effects of topical glyceryl trinitrate (GTN) in the treatment of tendinopathies. Design A systematic review of published randomised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback